As of 2026-01-04, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -229.82 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -229,925.00%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 229,925.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -229.82 - -229.82 | -229.82 | -229,925.00% |
| P/E | (665.57) - (886.21) | (825.07) | -825172.3% |
| DDM - Stable | (286.76) - (833.83) | (560.29) | -560393.8% |
| DDM - Multi | (232.61) - (555.56) | (331.30) | -331400.1% |
| Market Cap (mil) | 0.07 |
| Beta | -2.63 |
| Outstanding shares (mil) | 0.65 |
| Enterprise Value (mil) | -4.92 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.09% |
| Cost of Debt | 5.00% |
| WACC | 7.88% |